Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-3849 in Opioid-Induced Constipation: Phase 2 Randomized Double-Blind Placebo-Controlled Study
jRCT2080221274Phase 2
- Sponsor
- Ono Pharmaceutical
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid-induced constipation (OIC) comparing ONO-3849 with Placebo (2 arms).
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on jRCT2080221274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221274.